UBS and former UBS Broker William Hobby put Claimants in Harm’s Way - Customer Claim filed by Mark Tepper law firm alleges
08 avr. 2019 09h36 HE | Mark A. Tepper, P.A.
FT. LAUDERDALE, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- The law firm of Securities Fraud Attorney Mark A. Tepper has filed claim against UBS [NYSE: UBS] on behalf of a Georgia couple who entrusted...
LOGO JPG.jpg
Eight Presentations at ASM Microbe Include Late Breaker From Cempra’s Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
02 juin 2017 07h15 HE | Cempra, Inc.
CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
28 avr. 2017 07h00 HE | Cempra, Inc.
CHAPEL HILL, N.C., April 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options
13 mars 2017 07h00 HE | Cempra, Inc.
CHAPEL HILL, N.C., March 13, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
LOGO JPG.jpg
Cempra to Present at 29th Annual ROTH Conference
03 mars 2017 07h00 HE | Cempra, Inc.
CHAPEL HILL, N.C., March 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and...
LOGO JPG.jpg
Cempra Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
28 févr. 2017 06h45 HE | Cempra, Inc.
—Management to host webcast and conference call today at 8:45 a.m. ET— CHAPEL HILL, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company...
LOGO JPG.jpg
Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI
24 févr. 2017 07h00 HE | Cempra, Inc.
—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in the study— CHAPEL HILL, N.C., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a...
LOGO JPG.jpg
Cempra to Report Fourth Quarter and Full Year 2016 Financial Results
14 févr. 2017 16h15 HE | Cempra, Inc.
CHAPEL HILL, N.C., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
CORRECTING and REPLACING -- Cempra to Present at Upcoming Investor Conferences
08 févr. 2017 09h41 HE | Cempra, Inc.
CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Cempra, Inc. (Nasdaq:CEMP), the Leerink Partners conference should be noted...
LOGO JPG.jpg
Cempra to Present at Upcoming Investor Conferences
08 févr. 2017 07h30 HE | Cempra, Inc.
CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...